New drug design, discovery and development: Retrospective and perspective views

Chinese Pharmaceutical Journal

Volumn 50, Issue 5, 1998, Pages 249-256

  Lien, Eric J ^a   Lien, Linda L L ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Biotechnology; Discovery and development; Lead discovery; Lead optimization; New drug design; QSAR and molecular modeling; Side effect minimization

Indexed keywords

ALPHA2A INTERFERON; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CAPTOPRIL; CARDIOVASCULAR AGENT; CELLULOSE PHOSPHATE; CENTRAL NERVOUS SYSTEM AGENTS; CHYMOPAPAIN; CYCLIC GMP PHOSPHODIESTERASE; DIURETIC AGENT; EPHEDRINE; IPRATROPIUM BROMIDE; LANSOPRAZOLE; MALATHION; MISOPROSTOL; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OKT 3; OMEPRAZOLE; PACLITAXEL; PRIMODERM; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAVASIN; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITODRINE; SILDENAFIL; SOMATREM; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL;

BIOTECHNOLOGY; DRUG DESIGN; DRUG DEVELOPMENT; FOOD AND DRUG ADMINISTRATION; HUMAN; IMPOTENCE; INHALATIONAL DRUG ADMINISTRATION; MOLECULAR MODEL; ORAL DRUG ADMINISTRATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RESEARCH; REVIEW; TRADITIONAL MEDICINE; ULCER;

EID: 0031793822     PISSN: 10161015     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Lien, E. J.; Gao, H.; Lien, L. L. In Search of Ideal Antihypertensive Drugs: Progess in Five Decades. Prog. Drug Res. 1994, 43, 43-86.
2. Lien, E. J. QSAR in Medicinal Chemistry: An Overview. Chinese Pharm. J. 1990, 42, 1-29.
3. Lien, E. J.; Das A.; Lien L. L. Modeling of Neuroleptics with and without EPS Side Effects. Chin. Pharm. J. 1996, 48, 387-396.
4. Ren, S. J.; Lien, L. L.; Lien, E. J. Molecular Modeling and Structural Analysis of Benzamide Derivatives with and without Extrapyramidal Syndrome Side Effects. Current Med. Chem. 1997, 4, 271-278.
5. Ren, S. J; Lien, E. J. Development of HIV Protease Inhibitors: A Survey. Prog. Drug Res. 1998, 57, (in press).
6. Lien, E. J.; Lien L. L. Pharmacists Handbook of Drugs (unpublished).
7. Robbers, J. E.; Speedie, M. K.; Tyler, V. E. Pharmacognosy and Pharmacobiotechnology; Williams & Wilkins: Baltimore. 1996, pp 1-337.
8. Lien, E. J.; Li, W. Y. Structure Activity Relationship Analysis of Anticancer Chinese Drugs and Related Plants; Oriental Healing Arts Institute: Long Beach, CA, 1985; pp 1-150.
9. Lien, E. J. U.S. New Drugs Digest. 1980-1986; Aurora Publishers: Nashville, 1987, pp 1-200.
10. Lien, E. J.; Das, A.; Lien, L. L. Molecular Modeling of Neuroleptics with and without EPS Side Effects. 11th European Symposium on QSAR: Computer-assisted Lead Finding and Optimization; Lausanne, Switzerland, Sept. 1-6, 1996; (Poster Session). Abstract No. 35D.
11. USAN Council, List No. 397 New Names. Clinic. Pharmacol. Therap. 1997, 62, 358-360.
12. Chen Liu, K. C. S.; Lee, S. S.; Lin, M. T.; Chang, C. W.; Liu, C. L.; Lin, J. Y.; Hsu, F. L.; Ren, S. J.; Lien E. J. Lignans and Tannins as Inhibitors of Viral Reverse Transcriptase and Human DNA Polymerase-α: QSAR Analysis and Molecular Modeling. Med. Chem. Res. 1997, 7, 168-179.
13. Lin, M. T.; Chen Liu, K. C. S.; Kuo, Y. H.; Chiou, J. F.; Ren, S. J.; Lien, E. J. SAR Analysis of the Epstein-Barr Virus DNA Polymerase Inhibitors. Chin. Pharm. J. 1998, 50, 13-24.
14. Lien, E. J.; Bui, H. H.; Ren, S. J.; Chen Liu, K. C. S.; Lin, M. T.; Lee, S. S.; Chiou, J. F. Epstein-Barr Virus DNA Polymerase Inhibitors from Chinese Herbs: Use of Preliminary Screening, Physicochemical Properties and Taxonomy for New Lead Generation. Chinese Pharm. J. 1988 (Submitted for publication).
15. Hussar, D. A. New Drugs of 1997. J. Am. Pharm. Assoc. 1998, 38, 155-195.
16. Wesler, R. R.; Greenlee, W. J.; Irvin, J. D.; Goldberg, M. R.; Prendergast, K.; Smith, R. D.; Timmermans, B. M. W. M. The Next Generation in Antihypertensive Therapy. J. Med. Chem. 1996, 39, 625-656.
17. Asbury, C. H. Orphan Drugs, in Encyclopedia of Pharmaceutical Technology; Swarbrick, J., Boylan, J. C., Eds.; Marcel Dekker: New York, 1995, pp 161-184.